IL91948A - Removal of immunoreactive components from a sample - Google Patents

Removal of immunoreactive components from a sample

Info

Publication number: IL91948A
Authority: IL; Israel
Prior art keywords: antibody; assay; supported; murine; improvement
Prior art date: 1988-10-26

Application number

IL9194889A

Other languages

English (en)

Hebrew (he)

Other versions

IL91948A0 (en

Original Assignee

Immunomedics

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-10-26

Filing date

1989-10-11

Publication date

1994-05-30

1989-10-11 Application filed by Immunomedics filed Critical Immunomedics

1990-06-10 Publication of IL91948A0 publication Critical patent/IL91948A0/xx

1994-05-30 Publication of IL91948A publication Critical patent/IL91948A/en

Links

238000003556 assay Methods 0.000 claims description 66
241001529936 Murinae Species 0.000 claims description 53
238000000034 method Methods 0.000 claims description 48
210000004369 blood Anatomy 0.000 claims description 37
239000008280 blood Substances 0.000 claims description 37
239000012491 analyte Substances 0.000 claims description 29
230000008569 process Effects 0.000 claims description 24
229920002313 fluoropolymer Polymers 0.000 claims description 23
230000006872 improvement Effects 0.000 claims description 18
239000007787 solid Substances 0.000 claims description 17
239000011230 binding agent Substances 0.000 claims description 15
239000002033 PVDF binder Substances 0.000 claims description 13
229920002981 polyvinylidene fluoride Polymers 0.000 claims description 13
102000036639 antigens Human genes 0.000 claims description 12
108091007433 antigens Proteins 0.000 claims description 12
239000012530 fluid Substances 0.000 claims description 12
239000000427 antigen Substances 0.000 claims description 11
239000003153 chemical reaction reagent Substances 0.000 claims description 10
238000002616 plasmapheresis Methods 0.000 claims description 9
239000000203 mixture Substances 0.000 claims description 8
241000283973 Oryctolagus cuniculus Species 0.000 claims description 5
241000283707 Capra Species 0.000 claims description 4
230000000295 complement effect Effects 0.000 claims description 4
NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims description 4
239000003440 toxic substance Substances 0.000 claims description 4
239000000439 tumor marker Substances 0.000 claims description 4
102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 3
108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 3
230000002494 anti-cea effect Effects 0.000 claims description 3
230000000694 effects Effects 0.000 claims description 3
108090000765 processed proteins & peptides Proteins 0.000 claims description 3
241000271566 Aves Species 0.000 claims description 2
241000283690 Bos taurus Species 0.000 claims description 2
231100000757 Microbial toxin Toxicity 0.000 claims description 2
241001494479 Pecora Species 0.000 claims description 2
208000006454 hepatitis Diseases 0.000 claims description 2
231100000283 hepatitis Toxicity 0.000 claims description 2
230000000813 microbial effect Effects 0.000 claims description 2
102000004196 processed proteins & peptides Human genes 0.000 claims description 2
150000003431 steroids Chemical class 0.000 claims description 2
OOIBFPKQHULHSQ-UHFFFAOYSA-N (3-hydroxy-1-adamantyl) 2-methylprop-2-enoate Chemical compound C1C(C2)CC3CC2(O)CC1(OC(=O)C(=C)C)C3 OOIBFPKQHULHSQ-UHFFFAOYSA-N 0.000 claims 1
108010067390 Viral Proteins Proteins 0.000 claims 1
231100000167 toxic agent Toxicity 0.000 claims 1
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 30
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 30
210000002381 plasma Anatomy 0.000 description 27
241000894007 species Species 0.000 description 21
239000000126 substance Substances 0.000 description 16
238000011282 treatment Methods 0.000 description 15
239000001913 cellulose Substances 0.000 description 12
229920002678 cellulose Polymers 0.000 description 12
BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 11
102000013529 alpha-Fetoproteins Human genes 0.000 description 11
108010026331 alpha-Fetoproteins Proteins 0.000 description 11
239000000700 radioactive tracer Substances 0.000 description 11
229920006370 Kynar Polymers 0.000 description 10
239000000725 suspension Substances 0.000 description 9
239000008188 pellet Substances 0.000 description 7
229920000136 polysorbate Polymers 0.000 description 6
229950008882 polysorbate Drugs 0.000 description 6
230000001413 cellular effect Effects 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
239000000463 material Substances 0.000 description 4
239000002245 particle Substances 0.000 description 4
231100000614 poison Toxicity 0.000 description 4
230000004044 response Effects 0.000 description 4
102000004641 Fetal Proteins Human genes 0.000 description 3
108010003471 Fetal Proteins Proteins 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
230000002411 adverse Effects 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
239000011521 glass Substances 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
238000011534 incubation Methods 0.000 description 3
-1 polytetrafluoroethylene Polymers 0.000 description 3
238000011160 research Methods 0.000 description 3
239000000758 substrate Substances 0.000 description 3
206010028980 Neoplasm Diseases 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
102100035703 Prostatic acid phosphatase Human genes 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
239000012062 aqueous buffer Substances 0.000 description 2
210000001072 colon Anatomy 0.000 description 2
238000012875 competitive assay Methods 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
244000005700 microbiome Species 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
229940068977 polysorbate 20 Drugs 0.000 description 2
108010043671 prostatic acid phosphatase Proteins 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
208000023275 Autoimmune disease Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
241000233866 Fungi Species 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
108010044467 Isoenzymes Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241001504519 Papio ursinus Species 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000012636 effector Substances 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940084986 human chorionic gonadotropin Drugs 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
239000013586 microbial product Substances 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000002574 poison Substances 0.000 description 1
229920002493 poly(chlorotrifluoroethylene) Polymers 0.000 description 1
239000005023 polychlorotrifluoroethylene (PCTFE) polymer Substances 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920002620 polyvinyl fluoride Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000012898 sample dilution Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
238000012546 transfer Methods 0.000 description 1
231100000611 venom Toxicity 0.000 description 1
210000001048 venom Anatomy 0.000 description 1
239000002435 venom Substances 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/545—Synthetic resin
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Cell Biology (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

IL9194889A 1988-10-26 1989-10-11 Removal of immunoreactive components from a sample IL91948A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US26261688A	1988-10-26	1988-10-26
US26261588A	1988-10-26	1988-10-26

Publications (2)

Publication Number	Publication Date
IL91948A0 IL91948A0 (en)	1990-06-10
IL91948A true IL91948A (en)	1994-05-30

Family

ID=26949348

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9194889A IL91948A (en)	1988-10-26	1989-10-11	Removal of immunoreactive components from a sample

Country Status (5)

Country	Link
EP (1)	EP0440722A4 (fr)
KR (1)	KR900701313A (fr)
CA (1)	CA2000861A1 (fr)
IL (1)	IL91948A (fr)
WO (1)	WO1990004976A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX352922B (es) *	2009-02-24	2017-12-14	Esbatech Alcon Biomed Res Unit	Métodos para identificar inmunoligadores de los antígenos de la superficie celular.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3843443A (en) *	1973-03-30	1974-10-22	J Fishman	Polypeptide materials bound to fluorocarbon polymers
US4685900A (en) *	1983-06-01	1987-08-11	Biospecific Technologies, Inc.	Therapeutic device
US4831118A (en) *	1987-08-07	1989-05-16	Scripps Clinic And Research Foundation	Flouroplastic immunoaffinity columns for purification of blood proteins
US4865841A (en) *	1987-10-23	1989-09-12	Imre Corporation	Methods and compositions for transient elimination of humoral immune antibodies

1989
- 1989-10-11 IL IL9194889A patent/IL91948A/en not_active IP Right Cessation
- 1989-10-13 WO PCT/US1989/004586 patent/WO1990004976A1/fr not_active Ceased
- 1989-10-13 EP EP19890912291 patent/EP0440722A4/en not_active Withdrawn
- 1989-10-17 CA CA002000861A patent/CA2000861A1/fr not_active Abandoned
1990
- 1990-06-26 KR KR1019900701368A patent/KR900701313A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
KR900701313A (ko)	1990-12-01
EP0440722A4 (en)	1992-01-02
CA2000861A1 (fr)	1990-04-26
IL91948A0 (en)	1990-06-10
WO1990004976A1 (fr)	1990-05-17
EP0440722A1 (fr)	1991-08-14

Legal Events

Date	Code	Title	Description
1996-08-04	RH	Patent void
2005-07-25	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
US4332783A (en)	1982-06-01	Process for immunologic determination tests
JP4270751B2 (ja)	2009-06-03	全血用クロマトグラフィーデバイス内のポリカチオンの中和
Venkatesan et al.	1993	ELISAs for parasitologists: or lies, damned lies and ELISAs
US4508829A (en)	1985-04-02	Method and kit for pregnancy detection
EP0468585B1 (fr)	1995-11-08	Elément analytique incorporé avec un réactif biologiquement actif et méthodes pour utiliser le réactif
US7824873B2 (en)	2010-11-02	Blood test kit
EP0166623A2 (fr)	1986-01-02	Test-sandwich à anticorps lectine
JP2001502795A (ja)	2001-02-27	血液型抗原および抗体の検出に有用な方法および装置
JP4086266B2 (ja)	2008-05-14	免疫測定方法
US4162895A (en)	1979-07-31	Mouse serum
US4307190A (en)	1981-12-22	Immunoassay using ascitic fluid
US4617262A (en)	1986-10-14	Assaying for circulating immune complexes with labeled protein A
IL91948A (en)	1994-05-30	Removal of immunoreactive components from a sample
EP0410893B1 (fr)	1995-10-04	Détection de l'anticorps et sa classe d'immunoglobuline
JP3550614B2 (ja)	2004-08-04	糖化ヘモグロビンの測定方法
US5017472A (en)	1991-05-21	Microflotation devices used for immunoassays and cell/molecular fractionation
CN114539401B (zh)	2022-06-24	一种磁微粒标记方法及检测试剂盒
JPH1123573A (ja)	1999-01-29	免疫学的測定方法
US5466611A (en)	1995-11-14	Method for the determination of antigens or antibodies in the presence of an immune complex
JPH06100603B2 (ja)	1994-12-12	特定の細菌ポリペプチド及びそれに対する抗体の定量法
JP2000180446A (ja)	2000-06-30	干渉作用を回避する方法及び試薬
US5637472A (en)	1997-06-10	Hydrazine derivatized cells
JP3663516B2 (ja)	2005-06-22	粒子試薬の合成後化学変性
CN115353565B (zh)	2023-03-10	磁微粒标记的抗体及其应用
JPH08327629A (ja)	1996-12-13	検体前処理方法